Fundz Deep Dive
Everything you need to win Silexion Therapeutics — in one platform.
Who to reach, what to say, and why now on Silexion Therapeutics — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Silexion Therapeutics — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Silexion Therapeutics collaborates with Evonik on advanced siRNA Formulation Development
Contract Type
partnership
Description
Silexion Therapeutics Corp. has announced its ongoing collaboration with Evonik, a global leader in specialty chemicals, for the development of an advanced siRNA formulation aimed at enhancing cancer treatment efficacy. The collaboration aims to create a sustained-release formulation that enhances the stability and targeting of SIL-204, for the treatment of KRAS-driven cancers.